Bank of New York Mellon’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
|
|||||
|
2025
Q1 | $1.03M | Sell |
|
|||||
|
2024
Q4 | $1M | Buy |
|
|||||
|
2024
Q3 | $1.11M | Sell |
|
|||||
|
2024
Q2 | $1.62M | Buy |
|
|||||
|
2024
Q1 | $1.02M | Sell |
|
|||||
|
2023
Q4 | $1.05M | Buy |
|
|||||
|
2023
Q3 | $810K | Buy |
|
|||||
|
2023
Q2 | $475K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $588K | Buy |
|
|||||
|
2021
Q4 | $573K | Sell |
|
|||||
|
2021
Q3 | $1.03M | Buy |
|
|||||
|
2021
Q2 | $856K | Buy |
|
|||||
|
2021
Q1 | $1.03M | Buy |
|
|||||
|
2020
Q4 | $935K | Sell |
|
|||||
|
2020
Q3 | $1.04M | Sell |
|
|||||
|
2020
Q2 | $1.44M | Buy |
|
|||||
|
2020
Q1 | $860K | Sell |
|
|||||
|
2019
Q4 | $1.61M | Buy |
|
|||||
|
2019
Q3 | $1.1M | Buy |
|
|||||
|
2019
Q2 | $1.6M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $421K | Buy |
|